Skip to Content

Aminosalicylic acid Pregnancy and Breastfeeding Warnings

Aminosalicylic acid is also known as: Paser

Aminosalicylic acid Pregnancy Warnings

Aminosalicylic acid has been assigned to pregnancy category C by the FDA. There are no controlled data in human pregnancy. Aminosalicylic acid is only recommended during pregnancy when there are no alternatives and benefit outweighs risk.

The U.S. Public Health Service, Centers for Disease Control, and the Infectious Diseases Society of America in their recommendations and reports on the treatment of tuberculosis advise that aminosalicylic acid has been used safely in pregnancy and that it should be used only if there are no alternatives for a pregnant woman who has mutidrug-resistant tuberculosis.

See references

Aminosalicylic acid Breastfeeding Warnings

Aminosalicylic acid is excreted into human milk. The effects in the nursing infant are unknown.

Following administration of a different preparation of salicylic acid to one patient resulted in a maximum concentration in the milk of 1 mcg/mL at 3 hours with a half-life of 2.5 hours. The maximum maternal plasma concentration was 70 mcg/mL at 2 hours.

See references

References for pregnancy information

  1. "Product Information. Paser Granules (aminosalicylic acid)." Jacobus Pharmaceutical Company, Princeton, NJ.
  2. American Thoracic Society, CDC, Infectious Diseases Society of America "Treatment of tuberculosis." MMWR Morb Mortal Wkly Rep 53 (2005): 1203

References for breastfeeding information

  1. "Product Information. Paser Granules (aminosalicylic acid)." Jacobus Pharmaceutical Company, Princeton, NJ.
  2. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 7th ed." Philadelphia, PA: Lippincott Williams & Wilkins (2005):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide